ЗНАЧЕНИЕ ОЦЕНКИ ПОЧЕЧНОЙ ФУНКЦИИ ПРИ ПОЧЕЧНО-КЛЕТОЧНОМ РАКЕ
https://doi.org/10.21886/2308-6424-2013-0-3-39-53
Аннотация
Об авторах
С. В. Евсеев
ГБОУ ВПО РостГМУ Минздрава России
Россия
Кафедра урологии и репродуктивного здоровья человека с курсом детской урологии-андрологии
Россия
Кафедра урологии и репродуктивного здоровья человека с курсом детской урологии-андрологии
А. А. Гусев
ГБОУ ВПО РостГМУ Минздрава России
Россия
Кафедра урологии и репродуктивного здоровья человека с курсом детской урологии-андрологии
Россия
Кафедра урологии и репродуктивного здоровья человека с курсом детской урологии-андрологии
Список литературы
1. Carson, W.J.: Tumors of the kidney: Histologic study / W.J Carson // Trans Sec Urol AMA – 1928.– P.114.
2. Grawitz, P.: Die sogenannten Lipome der Niere / P. Grawitz // Virchows Arch. – 1883. – V.93. – P.39.
3. Birch-Hirschfeld, F.V. Zentralbl Krankh Horn Sex Org / F.V. Birch-Hirschfeld, A. Doederlein. – 1894 – Vol.3
4. Танаго, Э. «Урология по Дональду Смиту» / Э. Танаго, Д. Маканинич // М.,изд. Практика, 2005. – с.372-388.
5. Ferlay, J. Globocan 2000 / J. Ferlay, F. Bray, P. Pisani, M. Parkin // IARCPress. Lyon. – 2001. – P.124.
6. Greenlee, R. T. Cancer statistics, 2000. CA / R.T. Greenlee, T. Murray, S. Bolden et al // Cancer J Clin. – 2000. – Vol.50. – P.7.
7. Landis, S.H. Cancer statistics: 1999 / S.H. Landis, T. Murray, S. Bolden, P.A. Wingo // CA Cancer J Clin. – 1999. – Vol.49 – P.8–31.
8. Jemal, A. Cancer statistics, 2009 / A. Jemal, R.C. Tiwari, T. Murray et al. // CA Cancer J Clin. – 2009. – Vol.54. – P.8.
9. Jacqmin, D. Renal cancer / D. Jacqmin, H. van Poppel, Z. Kirkali, G. Mickisch // Eur Urol. – 2001. – Vol.39. – P.361-369.
10. Аксель, Е.А. Заболеваемость зло- качественными новообразованиями мочевых и мужских половых органов в России в 2003 г. / Е.А. Аксекль // Он- коурология. – 2005. – №1. – С.6-9.
11. Chow, W.H. Rising incidence of renal cell cancer in the United States / W.H. Chow, S.S. Devesa, J.L. Warren, J.F. Fraumeni // JAMA. – 1999. – Vol.281. – P.1628-3111.
12. Pantuck, The changing natural history of renal cell carcinoma / A.J. Pantuck, A. Zisman, A.S. Belldegrun // J Urol. – 2001. – Vol.166. – P.1611.
13. Аляев, Ю.Г. Локализованный и местно-распространенный рак почки: нефрэктомия или резекция? / Ю.Г. Аля- ев, А.А. Крапивин // Онкоурология – 2005. – №1. – С.10-15.
14. Jayson, M. Increased incidence of serendipitously discovered renal cell carcinoma / M. Jayson, H. Sanders // Urology. – 1998. – Vol.51. P.203.
15. Konnak, J. W. Renal cell carcinoma as an incidental finding / J.W. Konnak, H.B. Grossman // J Urol. – 1985. – Vol.134. – P.1094.
16. Natural history of renal masses followed expectantly / W. Kassouf, A.G. Aprikian, M. Laplante, S. Tanguay // J Urol. – 2004. – Vol.171. – P.111-113.
17. Аль-Шукри, С.Х. Опухоли мочеполовых органов / С.Х. Аль-Шукри, В.Н. Ткачук // С-Пб.,2000. – С.17-45.
18. The changing pattern of kidney cancer incidence and mortality in Europe / F. Levi, J. Ferlay, C. Galeone et al. // BJU Int. – 2008. – Vol.101(8). – P.949–958.
19. Global increase in kidney cancer incidence / A. Mathew, S.S. Devesa et al. // Eur J Cancer Prev. – 2002. – Vol.11(2). – P.171-178.
20. Chow, W.H. Re: rising incidence of small renal masses: a need to reassess treatment effect / W.H. Chow, W.M. Linehan, S.S. Devesa // J Natl Cancer Inst. – 2007. – 99. – P.569–570; author reply P.570-571.
21. Novick, A.C. Guideline for Management of the Clinical Stage 1 Renal Mass / A.C. Novick, S.C. Campbell // 2009.
22. Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease / N.H. Lopes, F. da Silva Paulitsch et al. // J. Thorac. Cardiovasc. Surg. – 2009. – Vol.137(6). – P.1443-1449.
23. Kim, H.L. Estimation and prediction of renal function in patients with renal tumor / H.L. Kim, S. K. Shah, W. Tan // J Urol – 2009. – Vol.181. – P.2451-2461.
24. A new equation to estimate glomerular filtration rate / A.S. Levey, L.A. Stevens, C.H. Schmid et al. // Ann Intern Med. – 2009. – Vol.150(9). – P.604-612.
25. CKD and risk of hospitalization and death with pneumonia / M.T. James, H. Quan, M. Tonelli et al // Am J Kidney Dis – 2009. – Vol.54. – P.24-32.
26. Stamler, J.Blood pressure, systolic and diastolic, and cardiovascular risks. US population data / J. Stamler, R. Stamler, J.D. Neaton // Arch Intern Med – 1993. – Vol.153. – P.598-615.
27. The timing of specialist evaluation in chronic kidney disease and mortality / K.S. Kinchen, J. Sadler, N. Fink et al // Ann Intern Med – 2002. – Vol.137. – P.479-486.
28. National Inventory of Clinical Laboratory Testing Services (NICLTS). Development and test distribution for 1996 / S.J. Steindel, W.J. Rauch, M.K. Simon, J. Handsfield // Arch Pathol Lab Med. – 2000. – Vol.124(8). – P.1201-1208.
29. Miller, WG. Reporting estimated GFR: a laboratory perspective / W.G. Miller WG. // Am J Kidney Dis. – 2008. – Vol.52(4). – P.645-648.
30. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study / K. Matsushita, E. Selvin, L.D. Bash et al. // Am J Kidney Dis. – 2010. – Vol.55. – P.648-659.
31. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study / S.L. White, K.R. Polkinghorne, R.C. Atkins, S.J. Chadban // Am J Kidney Dis. – 2010. – Vol.55. – P.660-670.
32. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors - is there a difference in mortality and cardiovascular outcomes? / W.C. Huang, E.B. Elkin, A.S.Levey et al. // J Urol – 2009. – Vol.181. – P.55.
33. Renal function assessment in the era of CKD: renewed emphasis on renal function centered patient care / B.R. Lane, E.D. Poggio, B.R. Herts et al. // J Urol – 2009. – Vol.182. – P.435.
34. Factors predicting renal functional outcome after partial nephrectomy / B.R. Lane, D.C. Babineau, E.D. Poggio et al. // J Urol – 2008. – Vol.180. – P.2363.
35. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a etrospective cohort study / W.C. Huang, A.S. Levey, A.M. Serio et al. // Lancet Oncol – 2006. – Vol.7. - P.735.
36. Matched comparison of radical nephrectomy vs nephronsparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney / W.K. Lau, M.L. Blute, A.L. Weaveret al. // Mayo Clin Proc – 2000. – Vol.75. – P.1236.
37. Rising incidence of small renal masses: a need to reassess treatment effect / J.M. Hollingsworth, D.C. Miller, S. Daignault et al. // J Natl Cancer Inst – 2006. – Vol.98. – P.1331.
38. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization / A.S. Go, G.M. Chertow, D. Fan et al. // N Engl J Med – 2004. – Vol.351/ – P.1296.
39. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?/ B.K. Hollenbeck, D.A. Taub, D.C. Miller et al. // Urology – 2006. – Vol.67. – P.254.
40. Prognostic Factors for Chronic Kidney Disease After Curative Surgery in Patients With Small Renal Tumors / G.J. Hwang, G.J. In, W.L. Jeong et al. // UROLOGY – 2009. – Vol.74(5). – P.1064–1069.
41. Hafez, K.S.Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging / K.S. Hafez, A.F. Fergany, A.C. Novick // J Urol. – 1999. – Vol.162. – P.1930-1933.
42. Natural history of chronic renal insufficiency after partial and radical nephrectomy / J. McKiernan, R. Simmons, J. Katz et al. // Urology – 2002. – Vol.59. – P.816-820.
43. Prognostic nomogram for renal insufficiency after radical or partial nephrectomy / M. Sorbellini, M.W. Kattan, M.E. Snyder et al. // J Urol. – 2006. – Vol.176. – P.472-476.
44. Renal function outcomes in patients treated for renal masses smaller than 4 centimetres by ablative and extirpative techniques / S.M. Lucas, J.M. Stern, M. Adibi et al // J Urol. – 2008. – Vol.179. – P.75-79.
45. Age-related incidence of sclerotic glomeruli in human kidneys / C. Kaplan, B. Pasternack, H. Shah et al // Am J Pathol. – 1975. – Vol.80. – P.227-234.
46. Preservation of renal function following partial or radical nephrectomy using 24-hour creatinine clearance / A.T. Clark, R.H. Breau, C. Morash et al. // Eur Urol. – 2008. – Vol.54. – P.143-149.
47. Use of contrast-enhanced computed tomography to measure clearance per unit renal volume: a novel measurement of renal function and fractional vascular volume / Y. Tsushima, M.J. Blomley, S. Kusano et al // Am J Kidney Dis – 1999. – Vol.33. – P.754
48. Renal computed tomography with 3- dimensional angiography and simultaneous measurement of plasma contrast clearance reduce the invasiveness and cost of evaluating living renal donor candidates / B.W. Lindgren, T. Demos, R. Marsan et al. // Transplantation – 1996. – Vol.61. – P.219.
49. Determination of the relative glomerular filtration rate of each kidney in man. Comparison between iohexol CT and 99mTc-DTPA scintigraphy / B. Frennby, T. Alme´n, B. Lilja et al. // Acta Radiol – 1995. – Vol.36. – P.410.
50. Brown, S.C.W. Iohexol clearance for the determination of glomerular filtration rate in clinical practice: evidence for a new gold standard / S.C.W. Brown, P.H. O’Reilly // J Urol.– 1991. – Vol.146. – P. 675.
51. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease / R.G. Cigarroa, R.A. Lange, R.H. Williams et al // Am J Med – 1989. – Vol.86. – P.649.
Рецензия
Для цитирования:
Евсеев С.В., Гусев А.А. ЗНАЧЕНИЕ ОЦЕНКИ ПОЧЕЧНОЙ ФУНКЦИИ ПРИ ПОЧЕЧНО-КЛЕТОЧНОМ РАКЕ. Вестник урологии. 2013;(3):39-53. https://doi.org/10.21886/2308-6424-2013-0-3-39-53
For citation:
Evseev S.V., Gusev A.A. VALUE ASSESSMENT OF RENAL FUNCTION IN RENAL CELL CARCINOMA. Urology Herald. 2013;(3):39-53. (In Russ.) https://doi.org/10.21886/2308-6424-2013-0-3-39-53
Просмотров: 895
Послать статью по эл. почте 
